SCN9A and peripheral neuropathy: The anticonvulsant lacosamide, acting on Nav1.3, Nav1.7, and Nav1.8 channels, was tested in patients with Nav1.7-mutation-related small-fibre neuropathy, with promising findings in a subgroup of patients [33].